For a long time, the claim has been made that the brains of conservative people are different than those of progressives.
Novartis plots new Pluvicto filing timeline after waiting for overall survival results
Novartis said Thursday in a brief, five-sentence press release that it plans to file for an expanded label for its prostate cancer treatment Pluvicto in